Johan Reyes
Pain Medicine · Cherry Hill, NJNPI 1750680948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,947 and has fallen 79.6% since, to $397 in 2025.
Across 206 payments — averaging $30.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Si-bone, Inc.$770
- Medtronic$610
- Boston Scientific$571
- Globus Medical$560
- MML US, Inc.$320
- plus $2K from 21 others
What the payments were for
- Travel & lodging$2264%
- Food & beverage$6,04796%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 29 | $1,377 |
| Si-bone, Inc. | 14 | $770 |
| Medtronic | 10 | $610 |
| Boston Scientific | 13 | $571 |
| Globus Medical(2 entities) | 13 | $560 |
| MML US, Inc. | 3 | $320 |
| Vertos Medical, Inc. | 7 | $292 |
| Collegium Pharmaceutical, Inc. | 37 | $265 |
| Painteq LLC | 1 | $184 |
| Spinal Elements, Inc. | 2 | $182 |
| Abbott | 6 | $161 |
| Biotronik NRO, Inc. | 3 | $151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $141 |
| International Rehabilitative Sciences, Inc | 1 | $131 |
| Daiichi Sankyo Inc. | 14 | $122 |
| MDD US Operations, LLC | 16 | $113 |
| Stryker | 1 | $66 |
| AstraZeneca | 5 | $59 |
| Kaleo, Inc. | 3 | $41 |
| Pacira Therapeutics, Inc. | 3 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Scilex Pharmaceuticals Inc. | 2 | $27 |
| Calyxo, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $15 |
| Pfizer | 1 | $15 |
| Almatica Pharma LLC | 1 | $12 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$411
- ReActiv8$299
- Medical Devices$296
- Senza$293
- iFuse Implant$251
- SUPERION$226
- PAINTEQ$184
- INTELLIS ADAPTIVESTIM$174
- mild Device Kit$148
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$144
- RS 4i Plus Sequential Stimulator$131
- INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$123
- ALIF$120
- Prospera$109
How this compares
$6,284 in reported general payments places this provider in the 80th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PercocetOxycodone Hcl/Acetaminophen | 50 | $169,842 |
| OxycontinOxycodone Hcl | 85 | $37,234 |
| BelbucaBuprenorphine Hcl | 34 | $26,224 |
| NucyntaTapentadol Hcl | 18 | $18,666 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 676 | $17,756 |
| Xtampza ErOxycodone Myristate | 41 | $16,578 |
| Lidocaine | 70 | $9,076 |
| Oxycodone Hcl | 485 | $8,425 |
| Tizanidine Hcl | 182 | $5,743 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $5,726 |
| MovantikNaloxegol Oxalate | 13 | $5,284 |
| Morphine Sulfate ErMorphine Sulfate | 258 | $4,808 |
| Gabapentin | 249 | $4,724 |
| Tramadol Hcl ErTramadol Hcl | 54 | $3,190 |
| Pregabalin | 115 | $2,237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Xtampza Er | $265 | $61,46893 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Cherry Hill
- Rajan GuptaCherry Hill$28K
- Steven McGrathCherry Hill$5K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.